MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches

N Amodio, L Raimondi, G Juli, MA Stamato… - Journal of hematology & …, 2018 - Springer
The deeper understanding of non-coding RNAs has recently changed the dogma of
molecular biology assuming protein-coding genes as unique functional biological effectors …

[HTML][HTML] Microenvironment drug resistance in multiple myeloma: emerging new players

L Di Marzo, V Desantis, AG Solimando, S Ruggieri… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Multiple myeloma (MM) drug resistance (DR) is a multistep transformation process based on
a powerful interplay between bone marrow stromal cells and MM cells that allows the latter …

DNA methylation aberrancies as a guide for surveillance and treatment of human cancers

G Liang, DJ Weisenberger - Epigenetics, 2017 - Taylor & Francis
ABSTRACT DNA methylation aberrancies are hallmarks of human cancers and are
characterized by global DNA hypomethylation of repetitive elements and non-CpG rich …

Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma

N Amodio, MA Stamato, AM Gullà, E Morelli… - Molecular cancer …, 2016 - AACR
Epigenetic abnormalities are common in hematologic malignancies, including multiple
myeloma, and their effects can be efficiently counteracted by a class of tumor suppressor …

[HTML][HTML] Reduced exosome miR-425 and miR-744 in the plasma represents the progression of fibrosis and heart failure

L Wang, J Liu, B Xu, YL Liu, Z Liu - The Kaohsiung journal of medical …, 2018 - Elsevier
Heart failure creates a leading public health burden worldwide and cardiac fibrosis is a
hallmark of pathological cardiac remodeling which was found in HF patients. In this study …

DNA methylation targeting: the DNMT/HMT crosstalk challenge

O Castillo-Aguilera, P Depreux, L Halby, PB Arimondo… - Biomolecules, 2017 - mdpi.com
Chromatin can adopt a decondensed state linked to gene transcription (euchromatin) and a
condensed state linked to transcriptional repression (heterochromatin). These states are …

miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma

M Rossi, E Altomare, C Botta, ME Gallo Cantafio… - Leukemia, 2021 - nature.com
Multiple myeloma (MM) is tightly dependent on inflammatory bone marrow
microenvironment. IL-17 producing CD4+ T cells (Th17) sustain MM cells growth and …

[HTML][HTML] Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature …

MR Pitari, M Rossi, N Amodio, C Botta, E Morelli… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Abstract miR-21 is an oncogenic microRNA (miRNA) with an emerging role as therapeutic
target in human malignancies, including multiple myeloma (MM). Here we investigated …

When oxidative stress meets epigenetics: implications in cancer development

Á García-Guede, O Vera, I Ibáñez-de-Caceres - Antioxidants, 2020 - mdpi.com
Cancer is one of the leading causes of death worldwide and it can affect any part of the
organism. It arises as a consequence of the genetic and epigenetic changes that lead to the …

Anti-tumor activity and epigenetic impact of the polyphenol oleacein in multiple myeloma

G Juli, M Oliverio, D Bellizzi, ME Gallo Cantafio… - Cancers, 2019 - mdpi.com
Olive oil contains different biologically active polyphenols, among which oleacein, the most
abundant secoiridoid, has recently emerged for its beneficial properties in various disease …